Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer
- Submitting institution
-
King's College London
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 137922592
- Type
- D - Journal article
- DOI
-
10.18632/oncotarget.3296
- Title of journal
- Oncotarget
- Article number
- -
- First page
- 5678
- Volume
- 6
- Issue
- 8
- ISSN
- 1949-2553
- Open access status
- Out of scope for open access requirements
- Month of publication
- January
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
6
- Research group(s)
-
-
- Citation count
- 16
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
